Literature DB >> 25267885

Genetics and pharmacogenetics of substance use disorders.

Pao-Luh Tao1, Li-Shiun Chen2, Chih-Ken Chen3, Yu-Li Liu1.   

Abstract

The "Genetics and Pharmacogenetics of Substance Use Disorder" session was chaired by Dr. Pao-Luh Tao and had three speakers. The speakers and their topics were: Dr. Li-Shiun Chen presented on Genomics and Personalized Medicine for Smoking Cessation Treatments, Dr. Chih-Ken Chen presented on the Genetics of Methamphetamine Abuse and Methamphetamine Psychosis, and Dr. Yu-Li Liu presented on a Pharmacogenomics Study in a Taiwan Methadone Maintenance Cohort.

Entities:  

Keywords:  genetics; methadone; methamphetamine; pharmacogenetics; smoking cessation; substance use disorders

Year:  2013        PMID： 25267885      PMCID： PMC4176940          DOI： 10.1016/j.jfda.2013.09.027

Source DB:  PubMed          Journal:  J Food Drug Anal            Impact factor:   6.079


  5 in total

1.  PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites.

Authors:  Hui-Ju Tsai; Sheng-Chang Wang; Jia-Ni Tian; Tsung-Kai Chang; Ing-Kang Ho; Chin-Fu Hsiao; Chia-Hui Chen; Happy Kuy-Lok Tan; Linen Lin; Chi-Shin Wu; Lien-Wen Su; Chieh-Liang Huang; Yi-Hong Yang; Ming-Lun Liu; Keh-Ming Lin; Yu-Li Liu
Journal:  J Clin Psychopharmacol       Date:  2013-02       Impact factor: 3.153

2.  Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.

Authors:  Kazuhiko Nakamura; Chih-Ken Chen; Yoshimoto Sekine; Yasuhide Iwata; A Anitha; El-Wui Loh; Nori Takei; Atsuko Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Katsuaki Suzuki; Yoshio Minabe; Kenji Tsuchiya; Kazuo Yamada; Masaomi Iyo; Norio Ozaki; Toshiya Inada; Nakao Iwata; Mutsuo Harano; Tokutaro Komiyama; Mitsuhiko Yamada; Ichiro Sora; Hiroshi Ujike; David M Ball; Takeo Yoshikawa; Shih-Ku Lin; Norio Mori
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

3.  OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.

Authors:  Yu-Ting Chen; Hsiao-Hui Tsou; Hsiang-Wei Kuo; Chiu-Ping Fang; Sheng-Chang Wang; Ing-Kang Ho; Yao-Sheng Chang; Chia-Hui Chen; Chin-Fu Hsiao; Hsiao-Yu Wu; Keh-Ming Lin; Andrew Ch Chen; Jyy-Jih Tsai-Wu; Yu-Li Liu
Journal:  J Hum Genet       Date:  2012-12-06       Impact factor: 3.172

4.  Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment.

Authors:  Li-Shiun Chen; Laura J Bierut
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

5.  A COMT gene haplotype associated with methamphetamine abuse.

Authors:  Sarah K Jugurnauth; Chih-Ken Chen; Michael R Barnes; Tao Li; Shih-Ku Lin; Hsing-Cheng Liu; David A Collier; Gerome Breen
Journal:  Pharmacogenet Genomics       Date:  2011-11       Impact factor: 2.089
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.